...
首页> 外文期刊>Cytotherapy >Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018
【24h】

Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018

机译:签名系列研讨会的诉讼程序“用于骨科和肌肉骨骼疾病的细胞疗法证明和未经证实的治疗方法 - 承诺,事实和幻想,”国际细胞疗法,加拿大,加拿大,2018年5月2日的国际社会

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The Signature Series Symposium “Cellular Therapies for Orthopaedics and Musculoskeletal Disease Proven and Unproven Therapies—Promise, Facts and Fantasy” was held as a pre-meeting of the 26thInternational Society for Cellular Therapy (ISCT) annual congress in Montreal, Canada, May 2, 2018. This was the first ISCT program that was entirely dedicated to the advancement of cell-based therapies for musculoskeletal diseases. Cellular therapies in musculoskeletal medicine are a source of great promise and opportunity. They are also the source of public controversy, confusion and misinformation. Patients, clinicians, scientists, industry and government share a commitment to clear communication and responsible development of the field. Therefore, this symposium convened thought leaders from around the world in a forum designed to catalyze communication and collaboration to bring the greatest possible innovation and value to patients with musculoskeletal conditions.
机译:签名系列研讨会“骨科和肌肉骨骼疾病的细胞疗法被证明和未经证实的治疗方法 - 承诺,事实和幻想”被举行为加拿大蒙特利尔蒙特利尔的26世纪年度大会的26世纪,5月2日, 2018年。这是第一个完全致力于推进肌肉骨骼疾病的细胞疗法的推进。 肌肉骨骼医学中的细胞疗法是伟大的承诺和机遇的源泉。 它们也是公共争议,混乱和错误信息的来源。 患者,临床医生,科学家,行业和政府分担了明确沟通和负责任的领域的承诺。 因此,这次研讨会召开了来自世界各地的思想领袖,该论坛旨在促进沟通和合作,为肌肉骨骼条件带来最大的可能创新和价值。

著录项

  • 来源
    《Cytotherapy》 |2018年第11期|共20页
  • 作者单位

    Department of Orthopedic Surgery and Biomedical Engineering Cleveland Clinic;

    Laboratory of Cellular Therapy Department of Medical and Surgical Sciences for Children &

    Adults University Hospital of Modena and Reggio Emilia;

    MTF Biologics;

    Adult Reconstruction-Adolescent and Young Adult Hip Service Washington University in St. Louis School of Medicine;

    Orthopaedic Soft Tissue Research Program Hospital for Special Surgery;

    Department of Orthopaedic Surgery UTHealth Medical School;

    INSERM;

    Advanced Regenerative Manufacturing Institute Manchester New Hampshire USA and Standards Coordinating Body;

    Orthopaedic Research Center and Department of Clinical Sciences Colorado State University;

    Vetbiobank;

    Skeletal Biology Section National Institute of Dental and Craniofacial Research National Institutes of Health Department of Health and Human Services;

    Department of Pathology and Laboratory Medicine Hospital for Special Surgery;

    Stem Cell Allogeneic Transplant Section National Institutes of Health;

    Regenerative Medicine Institute National University of Ireland;

    Steadman Philippon Research Institute;

    Department of Orthopaedic Surgery Stanford University;

    University of Vermont College of Medicine;

    Department of Biomedicine University Hospital of Basel University of Basel;

    Clinical Immunology and Osteoarticular Diseases Therapeutic Unit H?pital Lapeyronie;

    Department of Orthopedic Surgery and Biomedical Engineering Cleveland Clinic;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞工程;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号